MFS
RNAC icon

Miller Financial Services’s Cartesian Therapeutics RNAC Stock Holding History

Miller Financial Services’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$136K Buy
22,143
+8,500
+62% +$60.6K 0.15% 110
2025
Q4 		$98.4K Buy
13,643
+2,000
+17% +$16.2K 0.12% 109
2025
Q3 		$119K Hold
11,643
– – 0.14% 109
2025
Q2 		$121K Buy
+11,643
New +$124K 0.15% 104

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Miller Financial Services's RNAC Position: Q1 2026 in Review

Miller Financial Services increased its Cartesian Therapeutics (RNAC) stake by 62% in Q1 2026, buying an estimated $60.6K and bringing the position to 22,143 shares worth $136K. The position accounts for 0.15% of the portfolio, ranked #110.

Miller Financial Services first reported a position in RNAC in Q2 2025 and has held it in 4 quarters since. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

  • Miller Financial Services held 22,143 shares of Cartesian Therapeutics worth $136K as of Q1 2026.
  • Miller Financial Services bought 8,500 Cartesian Therapeutics shares in Q1 2026, an estimated $60.6K.
  • Cartesian Therapeutics made up 0.15% of Miller Financial Services's portfolio in Q1 2026, its #110 holding.
  • Miller Financial Services first reported a position in Cartesian Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on Miller Financial Services's 13F filing for Q1 2026, filed 4 May 2026.